Therapy-related leukemia associated with alkylating agents

Medical and Pediatric Oncology
S M Davies

Abstract

The leukemogenic potential of alkylating agents has been known for many years and almost all alkylating agents in clinical use have been shown to increase the risk of leukemia. With these drugs the risk of leukemia appears to increase with increasing patient age, as does the risk of de novo myeloid leukemia in the population. Susceptibility to alkylating agent-associated leukemia is influenced by the genetic constitution of the patient, and by the nature of the exposure. To illustrate the importance of these factors in etiology of leukemia, this paper discusses the contribution of disorders such as Fanconi anemia and neurofibromatosis to susceptibility to alkylating agent-associated leukemia. This paper also discusses the contribution of alkylating agents and other therapeutic exposures in the etiology of leukemias occurring after autologous bone marrow transplant.

References

Jun 1, 1978·The Journal of Pediatrics·J L Bader, R W Miller
Dec 1, 1978·The Journal of Pediatrics·E A McKeenJ J Mulvihill
Jul 1, 1979·The British Journal of Surgery·I M ModlinR B Welbourn
Sep 1, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·N J ChaoS J Forman
Apr 17, 1986·The New England Journal of Medicine·S A SørensenA Nielsen
Dec 1, 1988·Brain : a Journal of Neurology·S M HusonD A Compston
Jan 1, 1988·Pediatric Hematology and Oncology·A L HartleyV Blair
Dec 17, 1985·Biochimica Et Biophysica Acta·R SaffhillP J O'Connor
Nov 1, 1984·Carcinogenesis·H Bartsch, R Montesano
Nov 1, 1994·British Journal of Cancer·C A StillerM Fitchett
Dec 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R M StoneA S Freedman
Jun 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·M M Le BeauC A Westbrook
Feb 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·L B TravisJ D Boice
Nov 1, 1996·British Journal of Haematology·R GovindarajanG Tricot
Mar 21, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M J LaughlinJ J Vredenburgh
May 9, 1998·Proceedings of the National Academy of Sciences of the United States of America·H LiangL Nagarajan
Oct 3, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J W FriedbergA S Freedman
Mar 1, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·I N MicallefA Z Rohatiner
Sep 1, 1961·The Biochemical Journal·P Brookes, P D Lawley

❮ Previous
Next ❯

Citations

Feb 7, 2002·Pharmacoepidemiology and Drug Safety
Aug 8, 2008·Bulletin of Experimental Biology and Medicine·T I FominaE A Timina
Nov 10, 2007·Current Oncology Reports·Dan S Gombos, And Patricia Chevez-Barrios
Jan 19, 2010·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Melanie Joannides, David Grimwade
Mar 26, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G KleinP Kaatsch
Jun 8, 2012·Nature Medicine·Rushdia Z YusufDavid T Scadden
Nov 6, 2010·Japanese Journal of Clinical Oncology·Yuko ArakiAtsushi Makimoto
Jun 24, 2006·Journal of Pediatric Hematology/oncology·Kudret CağlarMünevver Büyükpamukçu
Mar 31, 2012·Neuro-oncology·Joachim M Baehring, Peter W Marks
Jan 9, 2008·Seminars in Hematology·Charlotte M Niemeyer, Irith Baumann
Oct 16, 2015·International Journal of Radiation Oncology, Biology, Physics·Rodrigue S AllodjiIbrahima Diallo
Jun 20, 2014·International Journal of Cancer. Journal International Du Cancer·Daniel K ChoiNobuko Hijiya
Jul 10, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·O VisserUNKNOWN RARECARE Working Group
Apr 29, 2015·Bulletin du cancer·Charlotte Demoor-GoldschmidtDominique Plantaz
Jan 22, 2009·Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi·Miho Maeda
Jun 12, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Antonio RuggieroRiccardo Riccardi
Mar 19, 2011·Pediatric Hematology and Oncology·Ali Varan, Rejin Kebudi
Mar 27, 2009·Pediatric Hematology and Oncology·In-sang Jeon, Dae Yong Yi
Aug 14, 2018·The British Journal of Radiology·Charlotte Demoor-Goldschmidt, Florent de Vathaire
Oct 27, 2020·International Journal of Cancer. Journal International Du Cancer·Rodrigue S AllodjiFlorent de Vathaire

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.